Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Rankin E.B.,,Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice,2008,Oncogene,110,10.1038/onc.2008.160,United States,Article,Philadelphia,0,Journal,2-s2.0-51649090078
Munirajan A.,,KIF1Bβ functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death,2008,Journal of Biological Chemistry,73,10.1074/jbc.M802316200,Japan;India;Japan,Article,Tosu;Chennai;Chuo-ku,1,Journal,2-s2.0-54049148638
Frew I.,,Combined Vhlh and Pten mutation causes genital tract cystadenoma and squamous metaplasia,2008,Molecular and Cellular Biology,34,10.1128/MCB.02132-07,Switzerland,Article,"Zurich ZH,",1,Journal,2-s2.0-47049111684
Frew I.,,pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation,2008,EMBO Journal,117,10.1038/emboj.2008.96,Switzerland,Article,"Zurich ZH,",0,Journal,2-s2.0-47049090632
Lei L.,,"Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein",2008,Molecular and Cellular Biology,96,10.1128/MCB.01580-07,United States,Article,New Haven,1,Journal,2-s2.0-43649100536
Kaelin W.G.,,Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway,2008,Molecular Cell,1709,10.1016/j.molcel.2008.04.009,United States;United States;United States,Review,Boston;Boston;Chevy Chase,1,Journal,2-s2.0-43649093915
Russell R.,,NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL,2008,EMBO Reports,30,10.1038/embor.2008.19,Canada,Article,Toronto,0,Journal,2-s2.0-43049141895
Rantanen K.,,Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation,2008,Molecular Biology of the Cell,49,10.1091/mbc.E07-11-1124,Finland,Article,Turku,0,Journal,2-s2.0-48249154559
Bishop T.,,Abnormal sympathoadrenal development and systemic hypotension in PHD3 <sup>-/-</sup> mice,2008,Molecular and Cellular Biology,148,10.1128/MCB.02041-07,United Kingdom,Article,Oxford,1,Journal,2-s2.0-43249108443
Chintalapudi M.,,Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells,2008,Carcinogenesis,32,10.1093/carcin/bgn019,United States,Article,Charleston,1,Journal,2-s2.0-41849131820
Mikhaylova O.,,The von Hippel-Lindau tumor suppressor protein and Egl-9-type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress,2008,Molecular and Cellular Biology,85,10.1128/MCB.01231-07,United States,Article,Cincinnati,1,Journal,2-s2.0-42149089909
Schlisio S.,,The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor,2008,Genes and Development,247,10.1101/gad.1648608,United States,Article,Boston,1,Journal,2-s2.0-41649116940
Ginouvès A.,,"PHDs overactivation during chronic hypoxia ""desensitizes"" HIFα and protects cells from necrosis",2008,Proceedings of the National Academy of Sciences of the United States of America,166,10.1073/pnas.0705680105,France,Article,Paris,1,Journal,2-s2.0-42449111722
Takeda K.,,Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins,2008,Blood,197,10.1182/blood-2007-09-114561,United States,Article,Farmington,0,Journal,2-s2.0-40949090791
Minamishima Y.,,Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure,2008,Blood,202,10.1182/blood-2007-10-117812,United States,Article,Boston,0,Journal,2-s2.0-42449163874
Kurban G.,,Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2,2008,Oncogene,62,10.1038/sj.onc.1210709,Canada,Article,Montreal,0,Journal,2-s2.0-38949161122
Lolkema M.P.,,Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor,2008,European Journal of Human Genetics,22,10.1038/sj.ejhg.5201930,Netherlands,Article,Utrecht,0,Journal,2-s2.0-37249036930
Escudier B.,,"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial",2007,Lancet,1886,10.1016/S0140-6736(07)61904-7,France,Article,Villejuif,0,Journal,2-s2.0-37349080670
Hickey M.M.,,Von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2α signaling and splenic erythropoiesis,2007,Journal of Clinical Investigation,88,10.1172/JCI32614,United States;United States,Article,Philadelphia;Philadelphia,1,Journal,2-s2.0-36849013228
Rixe O.,,Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study,2007,Lancet Oncology,400,10.1016/S1470-2045(07)70285-1,France,Article,Paris,0,Journal,2-s2.0-35448934762
Yang H.,,pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2,2007,Molecular Cell,126,10.1016/j.molcel.2007.09.010,United States,Article,Boston,1,Journal,2-s2.0-34948883495
Yuen J.S.P.,,The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma,2007,Oncogene,72,10.1038/sj.onc.1210474,United Kingdom,Article,Oxford,1,Journal,2-s2.0-34948858983
Lolkema M.,,The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2,2007,FEBS Letters,40,10.1016/j.febslet.2007.08.050,Netherlands,Article,Utrecht,1,Journal,2-s2.0-34548684136
Franovic A.,,Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer,2007,Proceedings of the National Academy of Sciences of the United States of America,181,10.1073/pnas.0702387104,Canada,Article,Ottawa,1,Journal,2-s2.0-34548803430
Li L.,,Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations,2007,Molecular and Cellular Biology,71,10.1128/MCB.00282-07,United States;United States,Article,Boston;Chevy Chase,1,Journal,2-s2.0-34547174217
Hughes M.,,HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation,2007,Cancer Cell International,12,10.1186/1475-2867-7-13,United States,Article,Garden City,1,Journal,2-s2.0-34447650633
Phung T.,,Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression,2007,Cancer Research,44,10.1158/0008-5472.CAN-06-3341,United States,Article,Boston,1,Journal,2-s2.0-34347244942
Kong X.,,Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein,2007,Journal of Biological Chemistry,62,10.1074/jbc.M700704200,United States,Article,Philadelphia,1,Journal,2-s2.0-34447522124
Zhang H.,,HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity,2007,Cancer Cell,569,10.1016/j.ccr.2007.04.001,United States,Article,Baltimore,1,Journal,2-s2.0-34247614521
Grosfeld A.,,Interaction of hydroxylated collagen IV with the von Hippel-Lindau tumor suppressor,2007,Journal of Biological Chemistry,48,10.1074/jbc.M611648200,United Kingdom,Article,Oxford,1,Journal,2-s2.0-34250308031
Thoma C.,,pVHL and GSK3β are components of a primary cilium-maintenance signalling network,2007,Nature Cell Biology,170,10.1038/ncb1579,Switzerland;Switzerland,Article,"Zurich ZH,;Zurich",0,Journal,2-s2.0-34247863920
Yoder B.,,Role of primary cilia in the pathogenesis of polycystic kidney disease,2007,Journal of the American Society of Nephrology,184,10.1681/ASN.2006111215,United States,Review,Birmingham,1,Journal,2-s2.0-34248151938
Gordan J.D.,,HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity,2007,Cancer Cell,526,10.1016/j.ccr.2007.02.006,United States;United States,Article,Philadelphia;Philadelphia,1,Journal,2-s2.0-34047156190
Rankin E.B.,,Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo,2007,Journal of Clinical Investigation,380,10.1172/JCI30117,United States,Article,Philadelphia,1,Journal,2-s2.0-34147124264
Yan Q.,,The hypoxia-inducible factor 2α N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo,2007,Molecular and Cellular Biology,127,10.1128/MCB.01514-06,United States;United States,Article,Boston;Chevy Chase,1,Journal,2-s2.0-33947250323
Liu Y.,,RACK1 Competes with HSP90 for Binding to HIF-1α and Is Required for O<inf>2</inf>-Independent and HSP90 Inhibitor-Induced Degradation of HIF-1α,2007,Molecular Cell,342,10.1016/j.molcel.2007.01.001,United States,Article,Baltimore,1,Journal,2-s2.0-33846254999
Escudier B.,,Sorafenib in advanced clear-cell renal-cell carcinoma,2007,New England Journal of Medicine,4018,10.1056/NEJMoa060655,France,Article,Villejuif,0,Journal,2-s2.0-33846148701
Motzer R.J.,,Sunitinib versus interferon alfa in metastatic renal-cell carcinoma,2007,New England Journal of Medicine,4576,10.1056/NEJMoa065044,United States,Article,New York,0,Journal,2-s2.0-33846181370
Evans A.,,VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail,2007,Molecular and Cellular Biology,196,10.1128/MCB.00892-06,Canada;Canada,Article,Toronto;Toronto,1,Journal,2-s2.0-33845724527
Schermer B.,,The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth,2006,Journal of Cell Biology,130,10.1083/jcb.200605092,Germany,Article,Freiburg im Breisgau,0,Journal,2-s2.0-33751209189
Takeda K.,,Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2,2006,Molecular and Cellular Biology,279,10.1128/MCB.00425-06,United States,Article,Farmington,1,Journal,2-s2.0-33750976389
Kim W.,,Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo,2006,EMBO Journal,158,10.1038/sj.emboj.7601300,United States,Article,Boston,0,Journal,2-s2.0-33749344471
Koivunen P.,,The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases,2006,Journal of Biological Chemistry,99,10.1074/jbc.M604628200,Finland,Article,Oulu,1,Journal,2-s2.0-33749410367
Peruzzi B.,,The von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells,2006,Proceedings of the National Academy of Sciences of the United States of America,84,10.1073/pnas.0606850103,United States,Article,Bethesda,1,Journal,2-s2.0-33749238874
Qian D.,,Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α,2006,Cancer Research,244,10.1158/0008-5472.CAN-05-4598,United States,Article,Baltimore,1,Journal,2-s2.0-33749006252
Bracken C.,,Cell-specific regulation of hypoxia-inducible factor (HIF)-1α and HIF-2α stabilization and transactivation in a graded oxygen environment,2006,Journal of Biological Chemistry,132,10.1074/jbc.M600288200,Australia;United Kingdom,Article,Adelaide;Dundee,1,Journal,2-s2.0-33747366672
Singla V.,,The primary cilium as the cell's antenna: Signaling at a sensory organelle,2006,Science,715,10.1126/science.1124534,United States,Review,San Francisco,0,Journal,2-s2.0-33746891890
Lutz M.,,Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells,2006,Cancer Research,98,10.1158/0008-5472.CAN-06-0501,United States,Article,New York,1,Journal,2-s2.0-33746886185
Hara S.,,Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1α in human salivary gland cancer cells,2006,Oral Oncology,56,10.1016/j.oraloncology.2005.10.016,Japan,Article,Toon,0,Journal,2-s2.0-33745354482
Esteban M.,,Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein,2006,Journal of the American Society of Nephrology,116,10.1681/ASN.2006020181,United Kingdom,Article,London,1,Journal,2-s2.0-33745819269
Roe J.,,p53 Stabilization and Transactivation by a von Hippel-Lindau Protein,2006,Molecular Cell,179,10.1016/j.molcel.2006.04.006,South Korea,Article,Seoul,1,Journal,2-s2.0-33646140913
Hu C.J.,,Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in stem cells,2006,Molecular and Cellular Biology,186,10.1128/MCB.26.9.3514-3526.2006,United States,Article,Philadelphia,1,Journal,2-s2.0-33646248422
Erler J.T.,,Lysyl oxidase is essential for hypoxia-induced metastasis,2006,Nature,1050,10.1038/nature04695,United States,,Stanford,0,Journal,2-s2.0-33646365644
Nakaigawa N.,,Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma,2006,Cancer Research,63,10.1158/0008-5472.CAN-05-0617,Japan,Article,Yokohama,1,Journal,2-s2.0-33645731190
Tang N.,,pVHL function is essential for endothelial extracellular matrix deposition,2006,Molecular and Cellular Biology,68,10.1128/MCB.26.7.2519-2530.2006,United States;United States,Article,San Diego;San Diego,1,Journal,2-s2.0-33644748673
Dayan F.,,The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α,2006,Cancer Research,192,10.1158/0008-5472.CAN-05-4564,France,Article,Paris,1,Journal,2-s2.0-33645735151
Esteban M.A.,,Regulation of E-cadherin expression by VHL and hypoxia-inducible factor,2006,Cancer Research,211,10.1158/0008-5472.CAN-05-2670,United Kingdom,Article,London,1,Journal,2-s2.0-33645748171
Kong X.,,Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α,2006,Molecular and Cellular Biology,215,10.1128/MCB.26.6.2019-2028.2006,United States,Article,Philadelphia,1,Journal,2-s2.0-33644780111
Rankin E.,,Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor,2006,Cancer Research,244,10.1158/0008-5472.CAN-05-3241,United States,Article,Philadelphia,1,Journal,2-s2.0-33645070535
Krishnamachary B.,,"Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B",2006,Cancer Research,308,10.1158/0008-5472.CAN-05-3719,United States;United States,Article,Baltimore;Baltimore,1,Journal,2-s2.0-33645090169
Covello K.L.,,"HIF-2α regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth",2006,Genes and Development,598,10.1101/gad.1399906,United States,Article,Philadelphia,1,Journal,2-s2.0-33644747418
Papandreou I.,,HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption,2006,Cell Metabolism,1288,10.1016/j.cmet.2006.01.012,United States,Article,Stanford,1,Journal,2-s2.0-33644622570
Kim J.,,HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia,2006,Cell Metabolism,1980,10.1016/j.cmet.2006.02.002,United States,Article,Baltimore,1,Journal,2-s2.0-33644614520
Kurban G.,,"Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis",2006,Cancer Research,91,10.1158/0008-5472.CAN-05-2560,Canada,Article,Montreal,1,Journal,2-s2.0-32944464205
Percy M.J.,,A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis,2006,Proceedings of the National Academy of Sciences of the United States of America,238,10.1073/pnas.0508423103,United Kingdom,Article,Belfast,1,Journal,2-s2.0-31444436640
Nakamura E.,,Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma,2006,Endocrine Pathology,29,10.1385/EP:17:2:97,Japan,Review,Kyoto,0,Journal,2-s2.0-33845684375
Thomas G.V.,,Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer,2006,Nature Medicine,496,10.1038/nm1337,United States,Article,Los Angeles,0,Journal,2-s2.0-30044432434
Datta K.,,Role of elongin-binding domain of von hippel lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma,2005,Oncogene,40,10.1038/sj.onc.1208912,United States,Article,Rochester,1,Journal,2-s2.0-28344435137
Hayashi M.,,Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1α is involved in trophoblast invasion under low-oxygen tension,2005,Endocrinology,52,10.1210/en.2005-0416,Japan,Article,Suita,1,Journal,2-s2.0-26844481561
Lee S.,,Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer,2005,Cancer Cell,421,10.1016/j.ccr.2005.06.015,United States,Article,Boston,1,Journal,2-s2.0-23644436667
Isaacs J.S.,,HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability,2005,Cancer Cell,639,10.1016/j.ccr.2005.06.017,United States;United States,Article,Charleston;Bethesda,1,Journal,2-s2.0-23644448721
Zagzag D.,,Stromal cell-derived factor-1α and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: Von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor,2005,Cancer Research,209,10.1158/0008-5472.CAN-04-4406,United States;United States;United States;United States,Article,New York;New York;New York;New York,1,Journal,2-s2.0-22244470409
Raval R.R.,,Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma,2005,Molecular and Cellular Biology,676,10.1128/MCB.25.13.5675-5686.2005,United Kingdom;United States,Article,Oxford;Philadelphia,1,Journal,2-s2.0-20744445650
Rankin E.B.,,Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice,2005,Molecular and Cellular Biology,118,10.1128/MCB.25.8.3163-3172.2005,United States,Article,Philadelphia,1,Journal,2-s2.0-16244381736
Petrella B.L.,,Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma,2005,Oncogene,138,10.1038/sj.onc.1208305,United States,Article,Hanover,1,Journal,2-s2.0-13944252559
Bento M.,,Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: Five new Caucasian patients,2005,Haematologica,47,,Portugal,Article,Coimbra,0,Journal,2-s2.0-13244272302
Aprelikova O.,,Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors,2004,Journal of Cellular Biochemistry,158,10.1002/jcb.20067,United States,Article,Bethesda,0,Journal,2-s2.0-4644237401
Appelhoffl R.J.,,"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor",2004,Journal of Biological Chemistry,701,10.1074/jbc.M406026200,,Article,,1,Journal,2-s2.0-4644318828
Marxsen J.,,Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases,2004,Biochemical Journal,240,10.1042/BJ20040620,Germany,Article,Lübeck,0,Journal,2-s2.0-4344645563
Stickle N.,,pVHL Modification by NEDD8 Is Required for Fibronectin Matrix Assembly and Suppression of Tumor Development,2004,Molecular and Cellular Biology,129,10.1128/MCB.24.8.3251-3261.2004,Canada,Article,Toronto,1,Journal,2-s2.0-1842557655
Koivunen P.,,Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases,2004,Journal of Biological Chemistry,284,10.1074/jbc.M312254200,Finland,Article,Oulu,1,Journal,2-s2.0-1642315195
Zimmer M.,,Inhibition of Hypoxia-Inducible Factor Is Sufficient for Growth Suppression of VHL-/- Tumors,2004,Molecular Cancer Research,198,,United States,Article,Boston,0,Journal,2-s2.0-1342280515
Kondo K.,,Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.,2003,PLoS biology.,429,,United States,Article,Boston,0,Journal,2-s2.0-2342597973
Staller P.,,Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL,2003,Nature,704,10.1038/nature01874,Switzerland;Switzerland,Article,"Zurich ZH,;Basel",0,Journal,2-s2.0-0141828145
Ma W.,,"Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene",2003,Cancer Research,101,,United States,Article,Frederick,0,Journal,2-s2.0-0141816848
Hirsilä M.,,Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor,2003,Journal of Biological Chemistry,578,10.1074/jbc.M304982200,Finland,Article,Oulu,0,Journal,2-s2.0-0043234538
Berra E.,,HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia,2003,EMBO Journal,960,10.1093/emboj/cdg392,France,Article,Nice,0,Journal,2-s2.0-0041465022
Arsham A.M.,,A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets,2003,Journal of Biological Chemistry,350,10.1074/jbc.M212770200,United States;United States,Article,Chicago;Philadelphia,1,Journal,2-s2.0-0042031047
Blouw B.,,The hypoxic response of tumors is dependent on their microenvironment,2003,Cancer Cell,318,10.1016/S1535-6108(03)00194-6,United States,Article,San Diego,1,Journal,2-s2.0-0041382820
Brugarolas J.,,TSC2 regulates VEGF through mTOR-dependent and -independent pathways,2003,Cancer Cell,426,10.1016/S1535-6108(03)00187-9,United States,Article,Boston,1,Journal,2-s2.0-0041920901
Maynard M.,,Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex,2003,Journal of Biological Chemistry,211,10.1074/jbc.M208681200,Canada,Article,Toronto,1,Journal,2-s2.0-0037837724
Kuznetsova A.,,Von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination,2003,Proceedings of the National Academy of Sciences of the United States of America,167,10.1073/pnas.0436037100,United States,Article,Cincinnati,1,Journal,2-s2.0-0344838401
Mack F.A.,,Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth,2003,Cancer Cell,131,10.1016/S1535-6108(02)00240-4,United States,Article,Philadelphia,1,Journal,2-s2.0-0038383678
Cioffi C.L.,,Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells,2003,Biochemical and Biophysical Research Communications,137,10.1016/S0006-291X(03)00453-4,United States,Article,Cambridge,0,Journal,2-s2.0-0037432686
Hergovich A.,,Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL,2003,Nature Cell Biology,274,10.1038/ncb899,Switzerland,Article,Basel,0,Journal,2-s2.0-0037223823
Pennacchietti S.,,Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene,2003,Cancer Cell,1018,10.1016/S1535-6108(03)00085-0,Italy,Article,Turin,1,Journal,2-s2.0-0037478437
Semenza G.,,Targeting HIF-1 for cancer therapy,2003,Nature Reviews Cancer,4569,10.1038/nrc1187,United States,Review,Baltimore,0,Journal,2-s2.0-0142166332
Ang S.,,Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia,2002,Nature Genetics,386,10.1038/ng1019,United States;United States,Article,Birmingham;Houston,0,Journal,2-s2.0-18744373593
Ivan M.,,Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor,2002,Proceedings of the National Academy of Sciences of the United States of America,453,10.1073/pnas.192342099,United States,Article,Boston,1,Journal,2-s2.0-0037108807
Hudson C.C.,,Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin,2002,Molecular and Cellular Biology,964,10.1128/MCB.22.20.7004-7014.2002,United States,Article,San Diego CA,1,Journal,2-s2.0-0036789574
Makino Y.,,Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus,2002,Journal of Biological Chemistry,263,10.1074/jbc.C200328200,Lithuania;Japan;Sweden,Article,Vilnius;Tokyo;Stockholm,1,Journal,2-s2.0-0037031808
Hewitson K.S.,,Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family,2002,Journal of Biological Chemistry,544,10.1074/jbc.C200273200,United Kingdom,Article,Oxford,1,Journal,2-s2.0-18544386401
Lando D.,,FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor,2002,Genes and Development,1057,10.1101/gad.991402,Australia,Article,Adelaide,1,Journal,2-s2.0-0037097861
Esteban-Barragán M.A.,,Role of the von Hippel-Lindau tumor suppressor gene in the formation of β1-integrin fibrillar adhesions,2002,Cancer Research,69,,Spain,Article,Madrid,0,Journal,2-s2.0-0037093099
Rafty L.,,Von Hippel-Lindau tumor suppressor protein represses platelet-derived growth factor B-chain gene expression via the Sp1 binding element in the proximal PDGF-B promoter,2002,Journal of Cellular Biochemistry,17,10.1002/jcb.10152,Australia,Article,Sydney,0,Journal,2-s2.0-0036237781
Chan J.,,Dissection of angiogenic signaling in zebrafish using a chemical genetic approach,2002,Cancer Cell,159,10.1016/S1535-6108(02)00042-9,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-0036527350
Maranchie J.K.,,The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma,2002,Cancer Cell,372,10.1016/S1535-6108(02)00044-2,United States,Article,Bethesda,1,Journal,2-s2.0-0036527785
Isaacs J.,,Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.,2002,The Journal of biological chemistry,545,10.1074/jbc.M204733200,United States,Article,Bethesda,1,Journal,2-s2.0-0037119415
Kondo K.,,Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein,2002,Cancer Cell,598,10.1016/S1535-6108(02)00043-0,United States,Article,Boston,1,Journal,2-s2.0-0036528246
Makino Y.,,Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression,2001,Nature,481,10.1038/35107085,Japan;Sweden,Article,Tokyo;Stockholm,0,Journal,2-s2.0-0035969508
Bruick R.,,A conserved family of prolyl-4-hydroxylases that modify HIF,2001,Science,1911,10.1126/science.1066373,United States,Article,Dallas,0,Journal,2-s2.0-0035834409
Masson N.,,Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation,2001,EMBO Journal,779,10.1093/emboj/20.18.5197,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0035903468
Yu F.,,HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation,2001,Proceedings of the National Academy of Sciences of the United States of America,590,10.1073/pnas.181341498,United States,Article,Philadelphia,1,Journal,2-s2.0-0035859692
Hoffman M.A.,,Von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF,2001,Human Molecular Genetics,304,10.1093/hmg/10.10.1019,United States,Article,Boston,0,Journal,2-s2.0-0035336706
Clifford S.,,Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis invon Hippel-Lindau disease,2001,Human Molecular Genetics,312,,United Kingdom;United Kingdom,Article,Birmingham;Newcastle,0,Journal,2-s2.0-0035339044
Ivan M.,,HIFα targeted for VHL-mediated destruction by proline hydroxylation: Implications for O<inf>2</inf> sensing,2001,Science,3427,10.1126/science.1059817,United States,Article,Chevy Chase,0,Journal,2-s2.0-0035917313
Jaakkola P.,,Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O<inf>2</inf>-regulated prolyl hydroxylation,2001,Science,3908,10.1126/science.1059796,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0035917808
Schoenfeld A.,,Endoplasmic reticulum/cytosolic localization of von hippel-lindau gene products is mediated by a 64-amino acid region,2001,International Journal of Cancer,34,10.1002/1097-0215(20010215)91:4<457::AID-IJC1072>3.0.CO;2-P,United States,Article,New York,0,Journal,2-s2.0-0035865958
Haase V.,,Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor,2001,Proceedings of the National Academy of Sciences of the United States of America,317,10.1073/pnas.98.4.1583,United States;United States,Article,Cambridge;Boston,1,Journal,2-s2.0-0035852668
Davidowitz E.,,VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling,2001,Molecular and Cellular Biology,94,10.1128/MCB.21.3.865-874.2001,United States,Article,New York,1,Journal,2-s2.0-0035136533
Ohh M.,,Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel - Lindau protein,2000,Nature Cell Biology,1142,10.1038/35017054,United States,Article,Boston,0,Journal,2-s2.0-0033776536
Kamura T.,,Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex,2000,Proceedings of the National Academy of Sciences of the United States of America,510,10.1073/pnas.190332597,United States,Article,Oklahoma City,1,Journal,2-s2.0-0034641615
Cockman M.,,Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein,2000,Journal of Biological Chemistry,854,10.1074/jbc.M002740200,United Kingdom,Article,London,1,Journal,2-s2.0-0034682783
Tanimoto K.,,Mechanism of regulation of the hypoxia-inducible factor-la by the von Hippel-Lindau tumor suppressor protein,2000,EMBO Journal,647,,Sweden,Article,Stockholm,0,Journal,2-s2.0-0034663894
Zhong H.,,Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics,2000,Cancer Research,1231,,United States,Article,Baltimore,0,Journal,2-s2.0-0034654174
Cohen H.T.,,An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association,1999,Biochemical and Biophysical Research Communications,43,10.1006/bbrc.1999.1767,United States,Article,Boston,0,Journal,2-s2.0-17144445958
Maxwell P.H.,,The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis,1999,Nature,3704,10.1038/20459,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0033587146
Koochekpour S.,,The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells,1999,Molecular and Cellular Biology,176,10.1128/MCB.19.9.5902,United States,Article,Frederick,1,Journal,2-s2.0-0032795938
Lieubeau-Teillet B.,,von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids,1998,Cancer Research,72,,Canada;Canada,Article,Toronto;Toronto,0,Journal,2-s2.0-0032211360
Carmeliet P.,,"Role of HIF-1α in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis",1998,Nature,2017,10.1038/28867,Belgium,Article,Ghent,0,Journal,2-s2.0-0032581277
Ryan H.,,HIF-1α is required for solid tumor formation and embryonic vascularization,1998,EMBO Journal,1249,10.1093/emboj/17.11.3005,United States,Article,San Diego,0,Journal,2-s2.0-0032100732
Pause A.,,The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal,1998,Proceedings of the National Academy of Sciences of the United States of America,207,10.1073/pnas.95.3.993,United States;,Article,Bethesda;,1,Journal,2-s2.0-0032477788
Ohh M.,,The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix,1998,Molecular Cell,383,10.1016/S1097-2765(00)80096-9,United States,Article,Boston,1,Journal,2-s2.0-0032085240
Maxwell P.H.,,Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth,1997,Proceedings of the National Academy of Sciences of the United States of America,875,10.1073/pnas.94.15.8104,United Kingdom,Article,Oxford,1,Journal,2-s2.0-0030816109
Mukhopadhyay D.,,The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity,1997,Molecular and Cellular Biology,296,10.1128/MCB.17.9.5629,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-0030834249
Gnarra J.,,Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene,1996,Proceedings of the National Academy of Sciences of the United States of America,451,10.1073/pnas.93.20.10589,United States,Article,Bethesda,1,Journal,2-s2.0-0029785838
Iliopoulos O.,,Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein,1996,Proceedings of the National Academy of Sciences of the United States of America,693,10.1073/pnas.93.20.10595,United States,Article,Boston,1,Journal,2-s2.0-0029785321
Vogel K.,,Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons,1995,Cell,133,10.1016/0092-8674(95)90470-0,United States,Article,Dallas,1,Journal,2-s2.0-0029120950
Iliopoulos O.,,Tumour suppression by the human von hippel-lindau gene product,1995,Nature Medicine,553,10.1038/nm0895-822,United States,Article,Boston,0,Journal,2-s2.0-0029090338
